how many glp-1 agonists are there List of Receptor for Diabetes & Weight Loss GLP-1 Receptor Agonists as Treatments
Description
KBP-089 and the GLP-1 analogue liraglutide were administered alone or in combination for 9 weeks in HFD rats
It has been reported that there is no reduction in its secretion in patients with T2DM [13] but a nearly total loss of insulinotropic effect is observed, even at supraphysiological concentrations, implying the existence of GIP resistance [14]
GLP-1 has been shown to effectively contribute to the functional integration between the CNS and peripheral metabolism
Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic -cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo
The GLP-1 receptor agonist market is growing rapidly, supported by rising obesity and diabetes prevalence, strong clinical outcomes, and increasing patient awareness
